Jason Barbour
Chief Executive Officer Echo Immune
Jason Barbour, PhD, is the Founder and CEO of Echo Immunotherapeutics, a clinical-stage biotechnology company building an end-to-end operating system for personalized mRNA cancer vaccines. He is a computational biologist and immunologist by training, with experience spanning bioinformatics, translational medicine, clinical development, and company building. Before founding Echo, he served on the faculty at the University of California, San Francisco and was an NIH-funded principal investigator. At Echo, he leads the development of an integrated platform connecting tumor sequencing, vaccine design, manufacturing, regulatory execution, clinical delivery, and longitudinal immune monitoring.
Seminars
Wednesday 2nd December 2026
The Immune System as a Design Variable: Building the Operating System for Personalized mRNA Cancer Vaccines
2:10 pm
- Why immune state matters: How prior therapy, disease biology, and immune competence influence the magnitude, quality, and durability of responses to personalized mRNA cancer vaccines
- Building the operating system: An end-to-end clinical and computational platform integrating patient identification, sequencing, vaccine design, manufacturing, regulatory execution, immune monitoring, and longitudinal clinical follow-up
- Learning from every patient: Using standardized, longitudinal clinical and immunologic data to continuously improve antigen selection, vaccine design, treatment strategies, and future personalized mRNA cancer vaccines
